Prognostic Impact of Surgical Intervention After Lenvatinib Treatment for Advanced Hepatocellular Carcinoma
Authors:
- 26 April 2021
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (12) , 7663-7672
Abstract
With the introduction of new molecular-targeted agents, an increasing number of patients with advanced hepatocellular carcinoma (HCC) are benefiting from sKeywords
Funding Information
- Okinaka Memorial Institute for Medical Research (2020)
This publication has 34 references indexed in Scilit:
- Early Decrease in α-Fetoprotein, but Not Des-γ-Carboxy Prothrombin, Predicts Sorafenib Efficacy in Patients with Advanced Hepatocellular CarcinomaOncology, 2011
- Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resectionLiver International, 2011
- Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinomaWorld Journal of Gastroenterology, 2011
- Liver Resection after Downstaging Hepatocellular Carcinoma with SorafenibInternational Journal of Hepatology, 2011
- New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinomaHepatology Research, 2010
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved ChemotherapyJournal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 KinaseClinical Cancer Research, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008